STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2019

Stockholders' Equity Note [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table summarizes the weighted average assumptions used to develop their fair value for the year ending December 31, 2019 and 2018:

	2019			2018
Grant date fair value	$	2.65		$	6.41
Risk-free interest rate	1.25		%	2.81		%
Expected volatility	44		%	45		%
Expected life in years	3.50			4.00
Dividend yield	—			—

Schedule of Share-based Compensation, Stock Options, Reserved Shares for Future Issuance, Activity

As of December 31, 2019, we reserved shares of common stock for future issuance as follows:

Options and RSUs outstanding	1,756,000
Shares available for future grant	387,000
Shares reserved	2,143,000

Share-based Compensation, Stock Options, Activity

The following table summarizes activity related to options during the year ended December 31, 2019.

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at the beginning of the year	1,494,000		$	10.99
Granted	721,000		6.50
Exercised	(143,000	)	5.65
Canceled	(387,000	)	10.17
Outstanding at the end of the year	1,685,000		$	9.71	3.1	$	1,336
Vested and expected to vest	1,424,000		$	9.83	3.0	$	1,052
Exercisable	769,000		$	10.43	2.2	$	350

Schedule of Summary of RSUs Activity

The following table summarizes activity related to RSUs during the year ended December 31, 2019.

	Shares		Weighted Average Grant-Date Fair Value
Outstanding at the beginning of the year	145,000		$	13.73
Granted	29,000		6.88
Released	(61,000	)	13.01
Forfeited	(42,000	)	13.85
Outstanding at the end of the year	71,000		$	11.52